Form 4: Cardlytics Officer Sells Shares for Tax Obligations

Cardlytics' Chief Legal & Privacy Officer, Nicholas Lynton, sold 6,253 shares of common stock to cover tax withholdings from vested restricted stock units.

Summary

• Nicholas Hollmeyer Lynton, the Chief Legal & Privacy Officer of Cardlytics, Inc. (CDLX), reported transactions involving the company's common stock.
• On January 1, 2026, Mr. Lynton acquired a total of 12,788 shares of common stock through the vesting and conversion of restricted stock units (RSUs).
• These acquisitions increased his beneficial ownership from 116,327 shares to 129,115 shares before the subsequent sale.
• On January 5, 2026, Mr. Lynton sold 6,253 shares of common stock at a weighted average price of $1.17 per share.
• The sale was executed solely to satisfy tax withholding obligations arising from the vesting of RSUs on January 1, 2026.
• Following these transactions, Mr. Lynton beneficially owns 122,862 shares of Cardlytics common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The transaction is a routine insider sale for tax purposes, not a discretionary sale, which typically does not signal a change in management's confidence in the company's future. The officer retains a substantial holding.

Positives

• The reported sale of shares was explicitly stated to be for tax withholding purposes, indicating it was not a discretionary sale based on a negative outlook for the company.
• The Chief Legal & Privacy Officer retains a significant beneficial ownership of 122,862 shares of common stock, demonstrating continued alignment with shareholder interests.

Negatives

• The weighted average sale price of $1.17 per share is relatively low, which could reflect the current market valuation of Cardlytics' stock.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is a report of insider transactions.

Management Comments

• The Reporting Person did not sell shares for any other purpose than to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on January 1, 2026.

Industry Context

Insider transactions, particularly those related to the vesting of equity awards and subsequent sales for tax purposes, are a routine occurrence across all industries. This specific transaction by a Cardlytics officer is consistent with standard compensation practices involving restricted stock units.

Stakeholder Impact

• Shareholders: The transaction is a routine insider sale for tax purposes and does not indicate a change in the company's fundamentals or management's long-term view. The officer maintains significant ownership.
• Employees: The vesting of RSUs and subsequent tax-related sales are standard components of executive compensation, reflecting ongoing employee retention and incentive structures.

Next Steps

• Remaining portions of the RSU awards will continue to vest quarterly over the subsequent three years, provided the Reporting Person continuously provides service to the Issuer through the vesting date.
• The 85,035-share RSU award will vest in its final installment on April 1, 2026, provided the Reporting Person remains employed by the Issuer.

Key Dates

Recommendation

The Form 4 filing details a routine insider transaction where the Chief Legal & Privacy Officer sold shares solely to cover tax obligations arising from RSU vesting. This is a non-discretionary sale and does not reflect a change in the officer's or company's outlook. The officer retains a substantial equity stake. Therefore, this specific filing does not provide sufficient new information to warrant a change from a 'hold' recommendation, as it does not signal any fundamental shift in the company's prospects.

Keywords

Cardlytics, CDLX, Insider Transaction, Form 4, Stock Sale, Restricted Stock Unit, RSU, Tax Withholding, Nicholas Lynton